¿Cómo abordarla? | 05 JUL 20

Somnolencia diurna excesiva en adultos

Un enfoque sobre las causas potenciales, el manejo y las indicaciones de la consulta especializada.
6
12
Autor/a: James Brown, Himender K Makker BMJ 2020;368:m1047
INDICE:  1. Texto principal | 2. Referencias bibliográficas
Referencias bibliográficas

 

1 Ohayon MM. From wakefulness to excessive sleepiness: what we know and still need to know. Sleep Med Rev 2008;12:129-41. 10.1016/j.smrv.2008.01.001 18342261

2 Young T, Evans L, Finn L, Palta M. Estimation of the clinically diagnosed proportion of sleep apnea syndrome in middle-aged men and women. Sleep 1997;20:705-6. 10.1093/sleep/20.9.705 9406321

3 Medicine AAoS. International classification of sleep disorders. Diagnostic and coding manual 2005:51-55.

4 Ohayon MM, Dauvilliers Y, Reynolds CF3rd. Operational definitions and algorithms for excessive sleepiness in the general population: implications for DSM-5 nosology. Arch Gen Psychiatry 2012;69:71-9. 10.1001/archgenpsychiatry.2011.1240 22213791

5 Horne JA, Reyner LA. Sleep related vehicle accidents. BMJ 1995;310:565-7. 10.1136/bmj.310.6979.565 7888930

6 British Lung Foundation. Obstructive sleep apnoea: toolkit for commissioning and planning local NHS services in the UK. 2015.

7 Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991;14:540-5. 10.1093/sleep/14.6.540 1798888

8 Sullivan SS, Kushida CA. Multiple sleep latency test and maintenance of wakefulness test. Chest 2008;134:854-61. 10.1378/chest.08-0822 18842919

9 British Thoracic Society. Position statement on driving and obstructive sleep apnoea. OSA, 2018.

10 Chattu VK, Sakhamuri SM, Kumar R, Spence DW. BaHammam AS, Pandi-Perumal SR. Insufficient sleep syndrome: is it time to classify it as a major noncommunicable disease?Sleep Sci 2018;11:56-64.

11 Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev 2002;6:97-111. 10.1053/smrv.2002.0186 12531146

12 Shochat T, Umphress J, Israel AG, Ancoli-Israel S. Insomnia in primary care patients. Sleep 1999;22(Suppl 2):S359-65.10394608

13 LeBlanc M, Mérette C, Savard J, Ivers H, Baillargeon L, Morin CM. Incidence and risk factors of insomnia in a population-based sample. Sleep 2009;32:1027-37. 10.1093/sleep/32.8.1027 19725254

14 Ford ES, Wheaton AG, Cunningham TJ, Giles WH, Chapman DP, Croft JB. Trends in outpatient visits for insomnia, sleep apnea, and prescriptions for sleep medications among US adults: findings from the National Ambulatory Medical Care survey 1999-2010. Sleep 2014;37:1283-93. 10.5665/sleep.3914 25083008

15 Qaseem A, Kansagara D, Forciea MA, Cooke M, Denberg TDClinical Guidelines Committee of the American College of Physicians. Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2016;165:125-33. 10.7326/M15-2175 27136449

16 Brasure M, Fuchs E, MacDonald R, etal . Psychological and behavioral interventions for managing insomnia disorder: an evidence report for a clinical practice guideline by the American College of Physicians. Ann Intern Med 2016;165:113-24. 10.7326/M15-1782 27136619

17 Steier J, Martin A, Harris J, Jarrold I, Pugh D, Williams A. Predicted relative prevalence estimates for obstructive sleep apnoea and the associated healthcare provision across the UK. Thorax 2014;69:390-2. 10.1136/thoraxjnl-2013-203887 24062427

18 Horvath CM, Jossen J, Kröll D, etal . Prevalence and prediction of obstructive sleep apnea prior to bariatric surgery-gender-specific  performance of four sleep questionnaires. Obes Surg 2018;28:2720-6. 10.1007/s11695-018-3222-z 29616468

19 Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol 2013;177:1006-14. 10.1093/aje/kws342 23589584

20 Chung F, Abdullah HR, Liao P. STOP-Bang Questionnaire: a practical approach to screen for obstructive sleep apnea. Chest 2016;149:631-8. 10.1378/chest.15-0903 26378880

21 Qaseem A, Holty JE, Owens DK, Dallas P, Starkey M, Shekelle PClinical Guidelines Committee of the American College of Physicians. Management of obstructive sleep apnea in adults: A clinical practice guideline from the American College of Physicians. Ann Intern Med 2013;159:471-83. 10.7326/0003-4819-159-11-201312030-00009 24061345

22 Douglas NJ. Systematic review of the efficacy of nasal CPAP. Thorax 1998;53:414-5. 10.1136/thx.53.5.414 9708236

23 Giles TL, Lasserson TJ, Smith BH, etal . Continuous positive airways pressure for obstructive sleep apnoea in adults. Cochrane Database Syst Rev 2006;1:CD00110610.1002/14651858.CD001106.pub2.

24 Alajmi M, Mulgrew AT, Fox J, etal . Impact of continuous positive airway pressure therapy on blood pressure in patients with obstructive sleep apnea hypopnea: a meta-analysis of randomized controlled trials. Lung 2007;185:67-72. 10.1007/s00408-006-0117-x 17393240

25 Ashrafian H, Toma T, Rowland SP, etal . Bariatric surgery or non-surgical weight loss for obstructive sleep apnoea? A systematic review and comparison of meta-analyses. Obes Surg 2015;25:1239-50. 10.1007/s11695-014-1533-2 25537297

26 Chapman JL, Kempler L, Chang CL, etal . Modafinil improves daytime sleepiness in patients with mild to moderate obstructive sleep apnoea not using standard treatments: a randomised placebo-controlled crossover trial. Thorax 2014;69:274-9. 10.1136/thoraxjnl-2013-203796 24287166

27 Chapman JL, Vakulin A, Hedner J, Yee BJ, Marshall NS. Modafinil/armodafinil in obstructive sleep apnoea: a systematic review and meta-analysis. Eur Respir J 2016;47:1420-8. 10.1183/13993003.01509-2015 26846828 28 Szentkiralyi A, Stefani A, Hackner H, etal . Prevalence and associated risk factors of periodic limb movement in sleep in two German population-based studies. Sleep (Basel) 201810.1093/sleep/zsy237. 30551198 29 Kornum BR, Knudsen S, Ollila HM, etal . Narcolepsy. Nat Rev Dis Primers 2017;3:16100. 10.1038/nrdp.2016.100 28179647

30 Faraco J, Mignot E. Immunological and genetic aspects of narcolepsy. Sleep Med Res 2011;2:39-4710.17241/smr.2011.2.2.39.

31 Sullivan SS, Guilleminault C. Emerging drugs for common conditions of sleepiness: obstructive sleep apnea and narcolepsy. Expert Opin Emerg Drugs 2015;20:571-82. 10.1517/14728214.2015.1115480 26558298

32 National Institute for Health and Care Excellence. Narcolepsy with or without cataplexy in adults: pitolisant. 2017. https://www.nice.org.uk/advice/es8/resources/narcolepsy-withor-without-cataplexy-in-adults-pitolisant-pdf-32181397189.

33 Billiard M, Sonka K. Idiopathic hypersomnia. Sleep Med Rev 2016;29:23-33. 10.1016/j.smrv.2015.08.007 26599679

34 Leu-Semenescu S, Nittur N, Golmard JL, Arnulf I. Effects of pitolisant, a histamine H3 inverse agonist, in drug-resistant idiopathic and symptomatic hypersomnia: a chart review. Sleep Med 2014;15:681-7. 10.1016/j.sleep.2014.01.021 24854887

35 National Institute for Health and Care Excellence. Obstructive sleep apnoea síndrome 2015. https://cks.nice.org.uk/obstructive-sleep-apnoea-syndrome.

36 Driver and Vehicle Licensing Agency. Assessing fitness to drive–a guide for medical professionals: Department for Transport Swansea, UK, 2016. https://www.gov.uk/ government/publications/assessing-fitness-to-drive-a-guide-for-medical-professionals.

 

 

Comentarios

Usted debe ingresar al sitio con su cuenta de usuario IntraMed para ver los comentarios de sus colegas o para expresar su opinión. Si ya tiene una cuenta IntraMed o desea registrase, ingrese aquí